{"metadata":{"topics":["501(c) organization","501(c)(3) organization","Accountability","Accountant","Accounting","Accounting standard","Accredited investor","Administrative division","Administrative law","Agencies of the United States government","Allen & Gledhill","Appeal","Applied ethics","Arbitration","Articles of association","Articles of incorporation","Artificial objects","Asset","Assignment (law)","Attorney's fee","Audit","Australia","Bank","Bankruptcy","Bee","Beneficial ownership","Bernard Tan","BioTime","Biopolis","Board of directors","Bond (finance)","Broker","Broker-dealer","Business","Business Development Company","Business economics","Business law","Business method patent","Business organizations","By-law","California","Car","Chairman","Charter","Chemistry","Chief executive officer","Child","Citizenship","Civil law (common law)","Civil law (legal system)","Cognition","Cognitive science","Collective rights","Commercial bank","Common law","Common stock","Communication","Companies","Company","Comparative law","Compensation of employees","Confidentiality","Conflict (process)","Conflict of laws","Consent","Consideration","Consolidation (business)","Construction","Consultant","Contract","Contract law","Contract of sale","Contractual term","Controversies","Conveyancing","Corporate capitalism","Corporate finance","Corporate governance","Corporate jargon","Corporate law","Corporate personhood","Corporation","Corporations","Corporatism","Courier","Court","Covenant (law)","Creditor","Culture","Currency","Custom","Customer","Damages","Data","Debenture","Decree","Deed","Deferral","Definition","Discovery (law)","Dividend","Doctrines","Document","Documents","Due diligence","Economic law","Economic sectors","Economy","Economy of the United States","Employment","Encumbrance","English language","Entity","Environmental law","Equity (finance)","Equity (law)","Equity securities","Escrow","Estate (law)","Ethical principles","Ethics","Evaluation","Executive officer","Executive order","Executor","Existence","Expense","Experience","Factor income distribution","Family","Fax","Fee","Fiduciary","Finance","Financial accounting","Financial adviser","Financial audit","Financial economics","Financial law","Financial markets","Financial regulation","Financial regulatory authorities","Financial services","Financial statement","Financial statements","Financial transaction","Foreign corporation","Form 10-K","Form 8-K","Form S-1","Form S-3","Franchising","Fraud","Generally Accepted Accounting Principles (United States)","Genome","Good faith","Governance","Government","Government agencies","Government and personhood","Government information","Government institutions","Government of the United States","Government-related organizations","Gross income","Hadassah Women's Zionist Organization of America","Hedge (finance)","Human activities","Human communication","Ice","Income","Income tax","Indemnity","Indenture","Independent agencies of the United States government","Industries","Information","Information science","Inheritance","Injunction","Inspection","Inspector","Institutional investor","Insurance","Intellectual works","Interest","Internal Revenue Code","Internal Revenue Service","International law","Intestacy","Invention","Investment","Investment Advisers Act of 1940","Investment company","Investment fund","Investor","Israel","Issued shares","Jargon","Jerusalem","Joint venture","Joint-stock company","Judgment (law)","Judiciaries","Judiciary of California","Jurisdiction","Jurisprudence","Justice","Know-how","Knowledge","Language","Law","Law and economics","Law of California","Law of Singapore","Law of obligations","Law of the United States","Lawsuit","Lawyer","Leadership","Lease","Legal communication","Legal concepts","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal liability","Legal literature","Legal opinion","Legal person","Legal procedure","Legal remedy","Legal writing","Letter of intent","Liability (financial accounting)","License","Lien","Limited company","Limited liability","Limited liability company","Loan","Mail","Management","Market (economics)","Marketing","Marketing plan","Massachusetts","Matter","Medicinal chemistry","Mergers and acquisitions","Metaphysics","Microeconomics","Misrepresentation","Monash University","Money","Morality","Mortgage law","NYSE American","Nationality","Natural person","Natural resources law","Net asset value","Net worth","New Deal agencies","New York City","Nothing","Number","Of counsel","Official documents","Omission (law)","One Marina Boulevard","Open government","Operation of law","Opinion","Option (finance)","Oral contract","Order (exchange)","Organization","Out-of-pocket expense","Ownership","Par value","Partnership","Patent","Patent application","Payment","Payments","Pension","Percentage","Personality traits","Philosophy","Political science","Politics","Postage stamp","Practice of law","Pre-emption right","Preferred stock","Prejudice","Prejudice (legal term)","President","Price","Principles","Private law","Private limited company","Private placement","Pro rata","Professional ethics","Profit (economics)","Property","Property law","Proprietary company","Prospectus (finance)","Proxy statement","Public administration","Public domain","Public law","Public policy","Public sphere","Question","Raffles City","Raffles Place","Reason","Recapitalization","Receipt","Registered office","Registration statement","Regulation","Regulation D (SEC)","Regulatory agency","Regulatory compliance","Research","Research and development","Revenue","Rice","Rights","Risk","Roman law","Rules","SEC Rule 144A","San Francisco","Savings and loan association","Science","Seal (emblem)","Securities (finance)","Securities Act of 1933","Securities Exchange Act of 1934","Securities and exchange commissions","Securities regulation in the United States","Security (finance)","Security interest","Self-regulatory organization","Separation of powers","Service industries","Service of process","Services (economics)","Severability","Share (finance)","Share capital","Shareholder","Shelf registration","Sibling","Signature","Singapore","Singapore dollar","Social institutions","Social issues","Sociological theories","Sources","Sovereign immunity","Staff (military)","Stamp duty","State Security Law in Bahrain","State court (United States)","Statute","Statutory authority","Stepfamily","Steven Weinberg","Stock","Stock certificate","Stock exchange","Stock market","Stock transfer agent","Subpoena","Subsidiary","Tax","Tax exemption","Technology","Theories of law","Third-party beneficiary","Tort of deceit","Treaty","Trust law","Trustee","U.S. Securities and Exchange Commission","U.S. state","Understanding","Underwriting","Unenforceable","United States","United States administrative law","United States business law","United States dollar","United States economic policy","United States federal policy","United States person","United States regulations","United States securities law","Urban, rural, and regional economics","Value (ethics)","Virtue","Voluntary association","Waiver","Walnut","Warrant (finance)","Warranty","Washington, D.C.","Wellington","WiCell","Wisconsin","Wisconsin Alumni Research Foundation","Witness","Writ","Writing","Written communication"],"person_names":["ariffeen bongso","b. reubinoff","benjamin eithan reubinoff","bernard tan","carl david strachan","carl e. gulbrandsen","carl gulbrandsen","carl strachan","cell international pte ltd","christine mummery","chu swee yeok","david munro pitt","david w. pitt","einat zisman","esi","esi share","esi shares","fong chui yee","frederick pera","holder","judith segall","khoo kay jin","lawrence chin","lee suet-fern","lippenberger","martin frederick","martin frederick pera","michael d. west","michael p. gray","nick gough","pharmbio growth fund pte ltd","richard s. soroko","soroko","steven seinberg","suzan lourdes","tan tiong gie bernard","thompson","welch"],"vars":{},"organization_names":["a person","allen & gledhill","associates pty ltd","biomedical sciences investment","biomedical sciences investment fund pte ltd","biotime","california corporate securities law","commission","commission a registration statement","curis inc.","desig","development company ltd","development company ltd.","es cell international pte ltd","es cell international pte ltd.","esi ordinary share","esi ordinary shares","free writing","free writing prospectus","gilbert llp","hadasit","hadasit medical research services and development company ltd","inc.","lily chan","majority other shareholders","monash investment holdings pty ltd","nus technology holdings pte","nus technology holdings pte ltd","nyse amex","other esi shares","other shareholder","other shareholders","other shareholders and beneficial shareholders","other shareholdersand","pte ltd","raffles city tower singapore","regis","registrable securities","resale restrictions","securities act. selling security holder","siac","singapore international a","soroko & gilbert llp","usd value","warrant shares","wicell research institute","wicell research institute inc"],"agreement_id":"32a35243439cacb48e9255be31fca5349b5183d76e42d62bb42c8122d8275f18","terms":["\"**Accredited Investor**\"","\"**Closing Date**\"","\"**Closing**\"","\"**Confidential Information**\"","\"**Disclosure Documents**\"","\"**Other Shareholders**\"","\"**Patent Application**\"","\"**Purchase P**","\"**Purchase P**rice**\"","\"**Purchaser**\"","\"**Registration Rights Agreement**\"","\"**Regulation S**\"","\"**Securities Act**\"","\"**Series A1 ESI Preferred Shares**\"","\"**Series A2 ESI Preferred Shares**\"","\"**Series A3 ESI Preferred Shares**\"","\"**U.S. Person**\"","\"**United States**\"","\"BioTime Shares**\"","**\") shall be satisfied by the allotment and issue by Purchaser to the Other Shareholders of common shares, no par value, of Purchaser (the \"BioTime Shares**\"","**(based on 0.00307680755416697 BioTime Shares per ESI Ordinary Share)**","***Signatures Begin On Next Page***","***Signatures Start on Following Page***","**/s/ Ariffeen Bongso**","**/s/ Benjamin Eithan Reubinoff**","**/s/ Fong Chui Yee**","**/s/ Martin Frederick Pera**","**ADDITIONAL COVENANTS**","**Accredited Investor Certification**","**Accredited Investor**","**Address and Nationality**","**Amendments and Waivers**","**Annex A**","**Arbitration**","**Authority**","**Authority; Enforceability**","**Breach of Closing Obligations**","**CLOSING**","**Certain Definitions**","**Chief Executive Officer**","**Chief Financial Officer**","**Closing; Closing Date**","**Conditions to Other Shareholders’ Obligation to Close**","**Conditions to Purchaser's Obligation to Close**","**Conduct of Indemnification Proceedings**","**Confidentiality**","**Contribution**","**Counterparts**","**Definitions and Interpretations.**","**Definitions**","**Delays and Omissions**","**Director**","**Documents Delivered By Other Shareholders and Beneficial Shareholders**","**Documents Delivered By Purchaser**","**ESI:**","**EXHIBIT B**","**EXHIBIT C**","**Enforceability**","**Entire Agreement**","**Entire Agreement; Amendment**","**Expenses**","**Foreign Resident Investor Certification**","**Further Assurances**","**GOVERNING LAW**","**General; Securities Subject to this Agreement**","**Governing Law**","**Grant of Rights**","**Headings**","**Holders of Registrable Securities**","**Indemnification by Designated Shareholders**","**Indemnification by the Company**","**Indemnification; Contribution**","**Injunctive Remedies**","**Interpretation**","**Interpretation****","**Investment Representations**","**Jurisdiction**","**MISCELLANEOUS**","**Minimum Number of ESI Shares to Be Sold**","**Miscellaneous**","**Name and Particulars of Beneficial Shareholders**","**Name and Particulars of Legal Shareholders**","**Name and Particulars**","**No Conflict**","**No Litigation**","**Non-Satisfaction /Waiver**","**Non-U.S. Person Status**","**Notice to Discontinue**","**Notices**","**Notices, etc.**","**Number and Class of Principal ESI Shares**","**Number of BioTime Shares per Principal ESI Share**","**Number of BioTime Shares to be allotted and issued to Legal Shareholders**","**Number of Other ESI Shares**","**OF OTHER SHAREHOLDERS AND BENEFICIAL SHAREHOLDERS**","**OTHER SHAREHOLDERS AND BENEFICIAL SHAREHOLDERS:**","**Obligations of the Company**","**Organization**","**Other Agreements**","**PRINCIPAL VENDORS**","**PURCHASER**","**Page**","**Permitted Assignees; Third Party Beneficiaries**","**President**","**Private Placement**","**Purchase Price**","**REGISTRATION RIGHTS AGREEMENT**","**REPRESENTATIONS AND WARRANTIES OF PURCHASER**","**REPRESENTATIONS, WARRANTIES, AND COVENANTS**","**Registrable Securities**","**Registration Expenses**","**Registration Procedures**","**Registration of BioTime Shares**","**Reports Under Exchange Act**","**Resale Restrictions.**","**Resale or Transfer of BioTime Securities**","**Responsibility for Satisfaction**","**Rules of Construction**","**S-3 Registration**","**SALE OF SHARES**","**SEC Documents; Financial Statements**","**Sale of Other ESI Shares**","**Seller Requirements**","**Severability**","**Share Splits, etc**","**Successors and Assigns**","**TABLE OF CONTENTS**","**TRANSFER AGREEMENT**","**Taxes**","**Termination of Shareholders’ Agreement**","**Third Party Rights**","**Time of the Essence**","**Title to Other ESI Shares**","**Transfer of Registration Rights****","**Validity of BioTime Shares**","**Waiver of Pre-Emption Rights**","**[Name and Address of Transferee]**","**[Name and Address of Transferor]**","**[Name of Transferee]**","**[Name of Transferor]**","**and to**","**however**","**provided**","**with a copy to**","’ fees and expenses) (each, a “Liability” and collectively, “ Liabilities”","“**Beneficial Shareholders**”","“**Business Day**”","“**Company**”","“**Designated Shareholder**”","“**Designated Shareholders’ Counsel**”","“**ESI Ordinary Shares**”","“**ESI Preferred Shares**”","“**ESI Shares**”","“**ESI**”","“**Excepted Holder**”","“**Excepted Shares**”","“**Exchange Act**”","“**Inspector**”","“**Inspectors**”","“**Liens**”","“**Majority Other Shareholders**”","“**Other ESI Shares**”","“**Parties**”","“**Pledgee**”","“**Principal ESI Shares**”","“**Principal Vendors**”","“**Purchaser’s Successor**”","“**Records**”","“**Registration Rights Agreement**”","“**SEC Reports**”","“**SHA Parties**”","“**SIAC**”","“**Shareholders’ Agreement**”","“**Transaction Documents**”","“**Transferee**”","“**Waived Other Shareholders Condition**”","“**Waived Purchaser Condition**”","“**related corporations**”","“**subsidiary**”","“**this Agreement**”","“Agreement”","“BioTime”","“ESI”","“Family Members”","“Indemnified Party”","“Indemnifying Party”","“Selling Security Holder”","“accredited investor.”"]}}